GLP-1 receptor agonists such as semaglutide and tirzepatide are FDA-regulated for chronic weight management in adults with a BMI of 30 or higher, or 27 with a weight-related condition. Las Vegas runs around the clock, and dealers, servers, performers and resort staff working overnight and rotating shifts rarely fit a daytime clinic into their week - even as the job keeps appearance and stamina front of mind. Telehealth works on their clock: a licensed Nevada physician reviews your online assessment under Nevada Revised Statutes §629.515, and compounded medication from an FDA-registered 503B pharmacy ships to your Las Vegas address. Monthly cost runs $199–$379 versus about $1,247 for brand-name Ozempic or Wegovy. Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Serving Las Vegas ZIP codes: 89101, 89102, 89104, 89109, 89119.
Local clinics serving Las Vegas 89118: Unicorn Medical Weight Loss & Medi Spa. Many patients compare these in-person options against licensed GLP-1 telehealth — prescribed online, shipped to the door.
For Las Vegas 89118 residents, the essentials on ozempic. Ozempic has become the household name for GLP-1s, but it is first and foremost a diabetes treatment: for weight loss, Wegovy (same molecule, higher dose) is the official indication.
Keeping a symptom journal helps the clinician decide on a relevant dose adjustment. Most of these effects ease as your body adapts and with a cautious dose increase; hydration and lighter meals help.
Local landmark: Unicorn Medical Weight Loss & Medi Spa (5920 S Rainbow Blvd #3, Las Vegas, NV 89118), rated 4.8/5 across 118 reviews. On the cost side, expect about $950-1,100/month brand-name without insurance; compounded semaglutide alternatives about $200-500/month. With a local obesity rate around 30.6% and 11.0% uninsured, demand for Ozempic runs high around Las Vegas 89118. For a Las Vegas 89118 resident, Ozempic is now largely managed remotely, home delivery included.
Generally no: they are most pronounced early in treatment and during dose increases, then ease off.
That is an off-label use. Many physicians prescribe it, but the FDA indication for weight loss is Wegovy (same active ingredient, semaglutide, at a higher dose).
Same molecule (semaglutide). Ozempic is dosed/approved for diabetes, Wegovy for chronic weight loss.
Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Licensed in Nevada. All prescriptions issued under Nevada Revised Statutes §629.515 and supervised by Nevada State Board of Medical Examiners.